Astrakhan, Astrakhan, Russian Federation
Copper complexes with aniline derivatives were synthesized and a comparative analysis of the anti-proliferative properties of the parent ligands and their complexes was carried out in relation to three tumor lines - MEL7, MCF-7, and PC3. A tendency towards the appearance and enhancement of the antiproliferative properties of compounds after complexation was revealed. The most active complex contained an o-F-substituted ligand, which causes activation of polyamine catabolism in a model of regenerating tissue, which shows the potential for such activation in tumor cells as well. This compound is recommended for further research.
Complex copper compounds, aniline derivatives, antiproliferative activity, screening, tumor cell lines
1. Anwanwan D., Singh S.K., Singh S., Saikam V., Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020 Jan; 1873(1): 188314. doi:https://doi.org/10.1016/j.bbcan.2019.188314. Epub 2019 Nov 1. PMID: 31682895; PMCID: PMC6981221.
2. Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019 Nov; 94(11): 1266-1287. doi:https://doi.org/10.1002/ajh.25595. Epub 2019 Oct 4. PMID: 31364186.
3. Davis L. E., Shalin S. C., Tackett A. J. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019; 20(11): 1366-1379. doi:https://doi.org/10.1080/15384047.2019.1640032. Epub 2019 Aug 1. PMID: 31366280; PMCID: PMC6804807
4. Casero R.A. Jr, Murray Stewart T., Pegg A.E. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018; 18(11): 681-695. doi:https://doi.org/10.1038/s41568-018-0050-3. PMID: 30181570; PMCID: PMC6487480.
5. Arisan E.D., Obakan P., Coker-Gurkan A., Calcabrini A., Agostinelli E., Unsal N.P. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells. Curr Pharm Des. 2014; 20(2): 180-8. doi:https://doi.org/10.2174/13816128113199990029. PMID: 23701543.
6. Ploskonos M.V., Syatkin S.P., Neborak E.V., Hilal A., Sungrapova K.Y., Sokuyev R.I., Blagonravov M.L., Korshunova A.Y., Terentyev A.A. Polyamine Analogues of Propanediamine Series Inhibit Prostate Tumor Cell Growth and Activate the Polyamine Catabolic Pathway. Anticancer Res. 2020 Mar; 40(3): 1437-1441. doi:https://doi.org/10.21873/anticanres.14085. PMID: 32132040.
7. Denoyer D., Clatworthy S.A.S, Cater M.A. Copper Complexes in Cancer Therapy. Met Ions Life Sci. 2018 Feb 5; 18 : /books/9783110470734/9783110470734-022/9783110470734-022.xml. doi:https://doi.org/10.1515/9783110470734-022. PMID: 29394035.
8. Syatkin S.P., Kirichuk A.A., Soldatenkov A.T., Kutyakov S.V., Neborak E.V., Shevkun N.A., Kuznetsova O.M., Skorik A.S., Terent'ev A.A. Screening of Some Dioxaboreninopyridine and Aniline Derivatives for Carcinogenic Properties Using a Model Cell-Free System of Regenerating Rat Liver. Bull Exp Biol Med. 2017 Apr; 162(6): 801-807. doi:https://doi.org/10.1007/s10517-017-3717-y. Epub 2017 Apr 21. PMID: 28429226.
9. Wang B.C., Wang L.J., Jiang B., Wang S.Y., Wu N., Li X.Q., Shi D.Y. Application of Fluorine in Drug Design During 2010-2015 Years: A Mini-Review. Mini Rev Med Chem. 2017; 17(8): 683-692. doi:https://doi.org/10.2174/1389557515666151016124957. PMID: 26471967.
10. Syatkin S.P., Neborak E.V., Khlebnikov A.I., Komarova M.V., Shevkun N.A., Kravtsov E.G., Blagonravov M.L., Agostinelli E. The investigation of structure-activity relationship of polyamine-targeted synthetic compounds from different chemical groups. Amino Acids. 2020 Feb; 52(2): 199-211. doi:https://doi.org/10.1007/s00726-019-02778-3. Epub 2019 Sep 13. PMID: 31520286.
